Valeant Pharmaceuticals Intl Inc (TSE:VRX) (NYSE:VRX) insider Paul Herendeen purchased 15,000 shares of Valeant Pharmaceuticals Intl stock in a transaction dated Tuesday, March 13th. The shares were bought at an average price of C$16.10 per share, with a total value of C$241,500.00.
Shares of VRX stock traded up C$0.32 during trading on Wednesday, hitting C$21.20. The company had a trading volume of 879,956 shares, compared to its average volume of 1,759,728. Valeant Pharmaceuticals Intl Inc has a 1 year low of C$11.20 and a 1 year high of C$30.56. The firm has a market cap of $7,690.00, a P/E ratio of 3.99 and a beta of -0.76.
About Valeant Pharmaceuticals Intl
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Receive News & Ratings for Valeant Pharmaceuticals Intl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals Intl and related companies with MarketBeat.com's FREE daily email newsletter.